Parikh et al. emphasized that while AFP and PIVKA-II offer value for the early detection of HCC, neither marker alone provides sufficient sensitivity or specificity to be used as a standalone surveillance tool [8]. This evidence concerns the gene AFP and hepatocellular carcinoma.